Idelalisib for treating chronic lymphocytic leukaemia

Supporting evidence

• Review decision

• Review decision – September 2018

• Review decision paper (PDF 450 KB)

  Published:

  28 September 2018

• Matrix of stakeholders (PDF 222 KB)

  Published:

  28 September 2018